Background: It has been reported that macrophage migration inhibitory factor (MIF) stimulated insulin secretion from pancreatic islet (3-cells in an autocrine manner, which suggests its pivotal role in the glucose metabolism. According to this finding, we evaluated MIF expression in cultured adipocytes and epididymal fat pads of obese and diabetic rats to investigate its role in adipose tissue. Materials and Methods: The murine adipocyte cell line 3T3-Ll was used to examine MIF mRNA expression and production of MIF protein in response to various concentrations of glucose and insulin. Epididymal fat pads of Otsuka Long-Evans Tokushima fatty (OLETF) and Wistar fatty rats, animal models of obesity and diabetes, were subjected to Northern blot analysis to determine MIF mRNA levels. Results: MIF mRNA of 3T3-L1 adipocytes was up-regulated by costimulation with glucose and insulin. Intra-
Introduction
Macrophage migration inhibitory factor (MIF) was originally identified more than 30 years ago as a lymphokine produced by activated T cells (1, 2) . MIF was recently found to be secreted from the pituitary gland and monocytes and macrophages, and has the potential to exacerbate endotoxemia (3, 4) . To date, a much broader role for MIF has been reported. It functions as an essential mediator in T cell activation and delayed-type hypersensitivity (5, 6) . It should also be noted that MIF counterregulates immunosuppressive effects of glucocorticoid (7) . MIF is not limited to immune cells and is ubiquitously expressed in various cells, including pancreatic (3- cells and adipocytes (8) (9) (10) . Recently, it was reported that MIF positively regulated insulin secretion from pancreatic (3-cells, depending on the glucose concentration (9) . This finding suggests the possibility that MIF plays an important role in the glucose metabolism.
Adipose tissue is not only an energy deposit but also secretes a variety of bioactive molecules such as leptin, plasminogen activator inhibitor-1, and tumor necrosis factor a (TNF-a) (11) (12) (13) . In particular, TNF-a expression of adipocytes is increased in obesity and exerts an inhibitory effect on the insulin signal transduction system, leading to insulin resistance (14, 15) . We cloned rat MIF cDNA, reported its physicochemical properties, and succeeded in the crystallization of both human and rat MIF (16) (17) (18) (19) . Following this, we reported the expression of MIF in adipocytes by Northern blot, Western blot, and immunohistochemical analyses (10) . In addition, we revealed that 3T3-L1, a murine adipocyte cell line, secreted MIF in response to TNF-a, and this process was mediated by tyrosine kinase (20) . These findings prompted us to investigate the role of MIF in adipose tissue.
In this study, we demonstrated that glucose and insulin could stimulate MIF mRNA expression in adipocytes in vitro. Furthermore, we found that intracellular MIF content increased, whereas the content in the culture medium decreased. On the other hand, we found downregulation of the MIF mRNA level in adipose tissues of two different animal models of noninsulin-dependent diabetes mellitus (NIDDM)-Otsuka Long-Evans Tokushima fatty (OLETF) rats and Wistar fatty rats. On the basis of these results, we discuss here the possible role of MIF in adipose tissue with regard to the pathophysiology of obesity and diabetes. Recombinant rat MIF was purified as previously described (17) . A polyclonal MIF antibody specific for rat MIF was generated by immunizing New Zealand white rabbits with purified recombinant rat MIF as described previously (2 1,22 20 min. After removal of the blocking solution, the samples were added in duplicate to individual wells and incubated for 1 hr. Aliquots of culture medium were collected to examine secreted MIF content. To determine the intracellular content of MIF, 3T3-L1 adipocytes were homogenized with sonication in PBS containing a cocktail of protease inhibitors (1 mM benzamidine, 1 mM phenylmethylsulfonylfluoride, 1 mM ethylenediaminetetraacetic acid, and 1 j,g/ml leupeptin) and centrifuged at 12,000 X g, and supernatants were subjected to the assay.
Materials and Methods

Reagents
After the plate was washed three times with PBS containing 0.05% Tween 20 (washing buffer), 50 ,ul of biotin-conjugated anti-MIF antibody was added to each well. Following incubation for 1 hr, the plate was again washed three times with the washing buffer. Avidin-conjugated horseradish peroxidase was added to each well, and the microtiter plate was incubated for 15 min. After washing three times, the substrate solution (50 ,ul) was added to each well. The substrate solution (10 ml) contained 8 mg of o-phenylenediamine and 4 ,ul of 30% H202 in citrate phosphatase buffer (pH 5.0). After incubation for 20 min, the reaction was terminated with 25 ,ul of 4 N sulfuric acid. The absorbance was measured at 492 nm using an ELISA plate reader (Bio-Rad, Model 3550). Intracellular MIF contents were normalized by total protein of cell lysates measured with a Micro BCA protein assay kit (Pierce, Rockford, IL).
Statistical Analysis
Results are expressed as the mean ± SD. All data were compared with the Student's t-test for unpaired data. P-values <0.05 were considered to be statistically significant. served when 3T3-L1 adipocytes were incubated with 400 mg/dl glucose, but no significant increase was observed in the presence of 100 mg/dl glucose or in the absence of glucose (Fig. 2B) . In a time-course study, up-regulation of the MIF mRNA level was seen at 8 hr after insulin stimulation and remained high up to 24 hr (Fig. 2C) (Fig. 3A) . The decrease in MIF content in the medium was more obvious when the adipocytes were costimulated with both glucose and insulin. On the other hand, the intracellular MIF protein level was increased by incubation with glucose and insulin in accordance with the up-regulation of MIF mRNA (Fig. 3B) (Fig. 6A) . Similarly, Northern blot analysis of isolated adipocytes from the epididymal fat pads of both 30-week-old and 46-week-old OLETF rats showed that MIF mRNA levels were those decreased to 0.5-fold and 0.6-fold of agematched LETO rats respectively (Fig. 6B) . These results indicated that some biological link might exist between the expression level of MIF and the pathophysiological states of obesity and diabetes.
Characteristics of Animals
The body weight of 30-week-old OLETF rats was significantly higher than that of LETO rats; however, no significant difference between the two groups of rats was seen at the age of 46 weeks (Table 1) . Feeding blood glucose levels in both 30-week-old and 46-week-old rats were significantly elevated, especially in 46-week-old rats.
Plasma MIF Concentration
The plasma MIF levels of OLETF rats of the 30-week-old and 46-week-old age-groups and of Wistar fatty rats were minimally changed (Fig. 7A,B) , despite the fact that MIF production in the adipose tissue of obesity/diabetes model rats was markedly decreased, as shown in Figure 6 . As for the experiment using pioglitazone, we found that plasma MIF levels of Wistar fatty rats were significantly increased by treat- duced by glucose in pancreatic islet 3-cells and isolated rat pancreatic islets (9 (24) . Accordingly, a high blood glucose level readily increases the intracellular glucose level of pancreatic islet 3-cells via GLUT2. Therefore, it is expected that MIF mRNA will be expressed in the islet 13-cells as a result of a high glucose level as previously reported (9) . On the other hand, GLUT4 expressed in adipocytes stimulates glucose transport in an insulin-dependent manner (25) . Thus, the glucose level in adipose tissue could be up-regulated by insulin, which results in the up-regulation of MIF mRNA only when these cells are sensitive to insulin. This is consistent with the finding that no significant increase in MIF mRNA level by stimulation with glucose and insulin was observed in undifferentiated 3T3-L1 cells, which do not express GLUT4 (data not shown).
Costimulation of adipocytes with glucose and insulin induced an increase in intracellular MIF content, in accordance with the up-regulation of mRNA expression. On the other hand, the stimulation caused a significant decrease in secreted MIF content. The reason for this decrease is not fully understood, but it is likely that the costimulation with glucose and insulin not only stimulated MIF mRNA expression but also enhanced the uptake of MIF protein by the adipocytes. To investigate the possible mechanism of MIF uptake by the cells, we examined the effect of cytochalasin B, an inhibitor of glucose transport. Cytochalasin B appeared to suppress MIF uptake by the cells, resulting in an increase in MIF content in the culture medium. Although cytochalasin B has other pharmacological effects, such as disorganization of actin bundle patterns, the current result strongly suggests that glucose transport played a pivotal role in determining intracellular and secreted MIF levels.
For further investigation, we employed two animal models, OLETF and Wistar fatty rats, in this study. These are known as animal models of NIDDM with obesity (26, 27 TNF-a mRNA is overexpressed in adipose tissues of some obese animals and humans when insulin resistance occurs (1 3,28) . This is because TNF-a has the potential to suppress the expression of GLUT4 in response to insulin by regulating its intracellular signaling pathway, which leads to insulin resistance (29) . Therefore, it is hypothesized that obesity causes insulin resistance mainly from overexpression of TNF-a in adipose tissue (15) . We previously reported that TNF-a increased the MIF mRNA level and MIF secretion into culture medium of 3T3-L1 adipocytes (10, 20) Furthermore, we administered pioglitazone to Wistar fatty rats to improve insulin resistance, then measured the plasma level of MIF. Pioglitazone, a thiazolidinedione derivative, is known as a ligand for the peroxisome proliferator-activated receptor y (PPARy) (32) . This agent induces differentiation of adipocytes, which results in improved insulin sensitivity in peripheral tissue in vivo (33) (34) (35) . The plasma MIF level was significantly increased by treatment with pioglitazone (Fig. 3B ), along with a decreased blood glucose level (Table 2) . Consistent with this, 3T3-L1 adipocytes treated with pioglitazone secreted more MIF protein than nontreated cells (Fig. 5A) . As for the pharmacological action, pioglitazone blocked the inhibitory effect of TNF-a on glucose uptake, but did not stimulate insulin-stimulated glucose uptake in 3T3-L1 adipocytes (36) . Thus, the increase in MIF content in culture medium in response to pioglitazone may not be related to intracellular glucose levels. Maturation of adipocytes might be intimately related with MIF production, because mature adipocytes produce more MIF protein than premature cells (20) . Indeed, pioglitazone is known to have the potential to stimulate cell differentiation (33 
